Hotline:
+ 49 (0) 2204 2918806
Manufacturer: GlobalData

OraSure Technologies, Inc. (OSUR) - Product Pipeline Analysis

NULL
SKU:GDMEPH1144PD / 163655
Publication Date:28.11.2012
Language version:English
Format:PDF
Report Type:Marktstudie
Lieferzeit:2-3 Tage
Nr of pages:28 Pages
Edition:0
Rating:Für diese Studie liegt keine Bewertung vor.
$750.00   *
* Click here to switch the currency you want to pay in.
Screenshots
OraSure Technologies, Inc. (OSUR) - Product Pipeline Analysis
More about this report
Table of Contents
Other relevant reports
Our guarantee
 

Numbers and facts for this report



- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.


- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Content of the report

Summary

OraSure Technologies, Inc. (OraSure) caters to the in vitro diagnostics segment. The company is dealing with development, manufacture and sale of oral fluid specimen collection devices, diagnostic products, and other medical devices. The company also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications. Its products are distributed through various hospitals, clinics, community-based organizations and other public health organizations, distributors, government clinical laboratories, government agencies, physicians’ offices, and commercial and industrial entities. Priority markets include in North America, Europe, Central and South America, and Australia.

Key business strategy includes increased focus on sturdy R&D activities help it in cost reduction and process improvement, quality assurance, and process control. Its R&D initiatives revolve around developing new manufacturing methods, improving existing manufacturing methods, developing new products, and improving the existing products. OraSure is headquartered in Pennsylvania, the US.

This report is a source for data, analysis and actionable intelligence on the OraSure Technologies, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.